BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Nonalcoholic fatty liver disease
1
Exhaled breath analysis in hepatology: State-of-the-art and perspectives
8/14/2019 1:31:33 PM | Browse: 9 | Download: 11
2
Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease
7/28/2019 10:51:57 AM | Browse: 16 | Download: 9
3
Freeze-dried Si-Ni-San powder can ameliorate high-fat-diet-induced non-alcoholic fatty liver disease
6/28/2019 12:22:27 PM | Browse: 46 | Download: 46
4
Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis
4/26/2019 3:40:00 AM | Browse: 67 | Download: 64
5
Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients
4/13/2019 6:00:06 AM | Browse: 82 | Download: 38
6
Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents
3/28/2019 9:14:41 AM | Browse: 73 | Download: 63
7
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
3/20/2019 5:32:10 AM | Browse: 66 | Download: 29
8
Role of cenicriviroc in the management of nonalcoholic fatty liver disease
12/27/2018 8:56:32 AM | Browse: 87 | Download: 37
9
Effects of alkaline-electrolyzed and hydrogen-rich water, in a high-fat-diet nonalcoholic fatty liver disease mouse model
12/7/2018 3:57:11 AM | Browse: 110 | Download: 60
10
Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle?
11/27/2018 1:56:41 PM | Browse: 107 | Download: 56
11
Mutual interaction between oxidative stress and endoplasmic reticulum stress in the pathogenesis of diseases specifically focusing on non-alcoholic fatty liver disease
10/17/2018 8:55:58 AM | Browse: 81 | Download: 68
12
PNPLA3 rs139051 is associated with phospholipid metabolite profile and hepatic inflammation in nonalcoholic fatty liver disease
9/26/2018 9:00:43 AM | Browse: 179 | Download: 63
13
Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis
8/27/2018 7:22:43 AM | Browse: 183 | Download: 79
14
Associations between nonalcoholic fatty liver disease and ischemic stroke
7/27/2018 4:31:20 PM | Browse: 139 | Download: 112
15
Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model”
7/19/2018 7:04:34 AM | Browse: 140 | Download: 85
16
Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis
6/15/2018 9:13:16 AM | Browse: 128 | Download: 85
17
Mediterranean diet and nonalcoholic fatty liver disease
5/18/2018 2:03:19 AM | Browse: 198 | Download: 115
18
Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease
5/18/2018 2:03:19 AM | Browse: 178 | Download: 62
19
Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma
5/11/2018 10:51:26 AM | Browse: 144 | Download: 75
20
Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
4/19/2018 7:56:07 AM | Browse: 176 | Download: 89
21
Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
4/11/2018 8:28:49 AM | Browse: 243 | Download: 96
22
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
3/16/2018 12:27:25 PM | Browse: 216 | Download: 87
23
Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: A PRISMA compliant systematic review and meta-analysis of pooled data
1/26/2018 8:09:36 AM | Browse: 232 | Download: 102
24
Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice
1/26/2018 2:31:05 AM | Browse: 213 | Download: 78
25
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
12/20/2017 2:49:19 AM | Browse: 232 | Download: 125
26
Palmitate induces fat accumulation by activating C/EBPβ-mediated G0S2 expression in HepG2 cells
11/20/2017 4:03:35 AM | Browse: 297 | Download: 178
27
Nonalcoholic fatty liver disease: Evolving paradigms
9/26/2017 12:18:54 AM | Browse: 389 | Download: 292
28
New botanical drug, HL tablet, reduces hepatic fat as measured by magnetic resonance spectroscopy in patients with nonalcoholic fatty liver disease: A placebo-controlled, randomized, phase Ⅱ trial
8/28/2017 6:54:48 AM | Browse: 265 | Download: 168
29
Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients
8/14/2017 1:56:00 AM | Browse: 224 | Download: 229
30
Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease
6/14/2017 9:25:57 AM | Browse: 278 | Download: 225
31
Nonalcoholic fatty liver disease: Diagnostic biomarkers
5/16/2017 6:56:36 AM | Browse: 389 | Download: 519
32
Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease
4/20/2017 3:58:56 PM | Browse: 688 | Download: 742
33
Patients with non-viral liver disease have a greater tumor burden and less curative treatment options when diagnosed with hepatocellular carcinoma
4/20/2017 3:58:56 PM | Browse: 327 | Download: 358
34
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis
2/26/2017 6:20:00 PM | Browse: 478 | Download: 526
35
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
11/26/2016 6:56:00 PM | Browse: 379 | Download: 481
36
bibliometric analysis of top 100 cited articles in nonalcoholic fatty liver disease research
11/25/2016 9:02:00 AM | Browse: 494 | Download: 397
37
Nonalcoholic fatty liver disease - A multisystem disease?
11/18/2016 3:13:00 PM | Browse: 531 | Download: 499
38
Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis
11/6/2016 3:43:00 PM | Browse: 274 | Download: 327
39
Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease
11/6/2016 3:43:00 PM | Browse: 511 | Download: 255
40
Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry
10/26/2016 5:33:00 PM | Browse: 347 | Download: 411
41
Oral administration of a non-absorbable plant cell-expressed recombinant anti-TNF fusion protein induces immunomodulatory effects and alleviates nonalcoholic steatohepatitis
10/20/2016 5:06:00 PM | Browse: 632 | Download: 376
42
Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease
9/8/2016 10:53:00 AM | Browse: 439 | Download: 789
43
Effects of different diets on intestinal microbiota and nonalcoholic fatty liver disease development
8/23/2016 6:33:00 PM | Browse: 409 | Download: 508
44
Mitochondrial DNA from hepatocytes as a ligand for TLR9: Drivers of nonalcoholic steatohepatitis?
8/15/2016 10:30:00 AM | Browse: 459 | Download: 431
45
Metabolic aspects of adult patients with nonalcoholic fatty liver disease
8/15/2016 10:30:00 AM | Browse: 773 | Download: 406
46
Herbal medicines and nonalcoholic fatty liver disease
8/4/2016 5:58:00 PM | Browse: 631 | Download: 487
47
Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy
6/2/2016 3:42:00 PM | Browse: 672 | Download: 732
48
Insulin resistance in development and progression of nonalcoholic fatty liver disease
5/13/2016 2:24:00 PM | Browse: 709 | Download: 671
49
Nonalcoholic fatty liver disease as a multi-systemic disease
4/19/2016 9:45:00 AM | Browse: 624 | Download: 332
50
Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease
2/25/2016 7:04:00 PM | Browse: 616 | Download: 922
Write to the Help Desk
© 2004-2018 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345